<h2 class="topline-heading">Topline</h2>
<p>Yeztugo, a twice-a-year antiviral shot to prevent HIV, was <a href="https://www.businesswire.com/news/home/20250520465880/en/Yeztugo-Lenacapavir-Is-Now-the-First-and-Only-FDA-Approved-HIV-Prevention-Option-Offering-6-Months-of-Protection" rel="nofollow noopener noreferrer" target="_blank" class="color-link" title="https://www.businesswire.com/news/home/20250520465880/en/Yeztugo-Lenacapavir-Is-Now-the-First-and-Only-FDA-Approved-HIV-Prevention-Option-Offering-6-Months-of-Protection" data-ga-track="ExternalLink:https://www.businesswire.com/news/home/20250520465880/en/Yeztugo-Lenacapavir-Is-Now-the-First-and-Only-FDA-Approved-HIV-Prevention-Option-Offering-6-Months-of-Protection" aria-label="approved">approved</a> by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS.</p>
<figure class="embed-base image-embed embed-1" role="presentation"><div class="image-embed__placeholder"><img src="https://specials-images.forbesimg.com/imageserve/685313dd059e27567876d44a/In-this-photo-illustration--a-vial-and-a-medical-syringe---/960x0.jpg?cropX1=50&amp;cropX2=3824&amp;cropY1=0&amp;cropY2=2516" alt="In this photo illustration, a vial and a medical syringe..." width="100%" height="auto"></div><figcaption><fbs-accordion><p class="color-body light-text" role="button">Yeztugo was approved by the FDA Wednesday. </p></fbs-accordion><small>(Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images</small></figcaption></figure>

 <div class="key-facts-element"> <p>The drug (which has the generic name lenacapavir) will become available in the U.S. following the approval, though it’s unclear who will initially have access to the drug.</p>  </div>


<em>This is a developing story. Check back for updates.</em>

Experts have said the injectable drug could help bring an end to HIV transmission.{ai:summary}<p>Yeztugo, an antiviral shot for HIV prevention, has received FDA approval, representing a significant step forward in the fight against AIDS. The drug, known generically as lenacapavir, will soon be available in the U.S., though initial access details remain unclear. </p><p>#health</p>

FDA Greenlights HIV Prevention Drug Yeztugo

Topline

Loading...